Results 71 to 80 of about 126,041 (267)

Omicron Therapeutics [PDF]

open access: yesASA Monitor, 2022
Steven L. Shafer, Richard Simoneaux
openaire   +1 more source

Omicron still on the rise

open access: yesNew Scientist, 2022
The BA.4 and BA.5 subvariants of omicron are driving an increase in covid-19 cases in many countries, reports Clare Wilson.
openaire   +2 more sources

Undergraduate Commencement Exercises Program, May 19, 2012 [PDF]

open access: yes, 2012
Bryant University Undergraduate Commencement Exercises Program, May 19 ...

core   +1 more source

Clinico-Epidemiological Profile of COVID-19 Patients with Omicron Variant Admitted in a Tertiary Care Center, South India

open access: yesInternational Journal of General Medicine, 2023
Theranirajan Ethirajan,1,* Gopalakrishnan Natarajan,2,* Rajendran Velayudham,3,* Pavithra Jayakumaran,4 Indumathi Karnan,1 Karthick Rajendran,5 Sudhakaran Doraisamy,6 Sripriya Chenakeswarar Sridhar,7 Purushoth Kumaran,1 Kabilan Kamaraj,1 ...
Ethirajan T   +11 more
doaj  

Adverse outcomes among pregnant women with COVID‐19 according to hospitalization status: A prospective individual participant data meta‐analysis in Europe and North America

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background Understanding the varied impact of COVID‐19 severity on pregnancy outcomes is crucial for informed clinical management and targeted interventions. Objective To evaluate the impact of COVID‐19 on pregnancy outcomes, distinguishing between pregnant women managed in primary care and those requiring hospitalization.
Odette de Bruin   +73 more
wiley   +1 more source

Immune histories and natural infection protection during the omicron era

open access: yesCommunications Medicine
Background Past immunological events can either enhance or compromise an individual’s future immune protection. This study investigated how different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) natural infection histories before an ...
Hiam Chemaitelly   +22 more
doaj   +1 more source

Molecular epidemiological characterization of SARS-CoV-2 Omicron variants in Quzhou, 2023–2024

open access: yesZhongguo gonggong weisheng
ObjectiveTo understand the epidemiological trends of SARS-CoV-2 Omicron variants and evolutionary variations of the spike protein in Quzhou city of Zhejiang province from 2023 to 2024.
Shiteng HUANG   +6 more
doaj   +1 more source

Gamma SARS‐CoV‐2 variant of concern infection repercussions on pregnancy outcomes: A translational cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study conduct viral genome sequencing among severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐infected pregnant and postpartum individuals, and investigates disease severity and maternal and perinatal outcomes considering variant of concern (VOC) and non‐VOC groups.
Guilherme M. Nobrega   +27 more
wiley   +1 more source

Antibiotic Use Among Hospitalized Patients with COVID-19 Infection (SARS-CoV-2 Omicron Variant) in Oman: A Single-center Retrospective Study

open access: yesOman Medical Journal
Objectives: To identify and evaluate the prescribing pattern of antibiotics among hospitalized patients with SARS-CoV-2, Omicron variant in Oman, focusing on the prevalence of antibiotic use, rates of simultaneous infection, and potential overuse ...
Alia Hani Ali Elatris   +4 more
doaj   +1 more source

Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review

open access: yesInfection and Drug Resistance, 2022
Nour Shaheen,1 Abdelrahman Mohamed,1 Almoatazbellah Attalla,1 Rehab Adel Diab,2 Sarya Swed,3 Abdulqadir J Nashwan,4 Ala’ Abdala Rababah,5 Mahmoud Tarek Hefnawy,6 Youssef Soliman,7 Omar Ahmed Abdelwahab,2 Mariam Tarek Desouki,1 Abdulrhman Khaity,8 Ahmed ...
Shaheen N   +14 more
doaj  

Home - About - Disclaimer - Privacy